close

MEDTOX Scientific, Inc. and its subsidiaries provide forensic and clinical laboratory services. It also manufactures and distributes diagnostic and related devices. The Laboratory Services segment offers workplace drug-of-abuse testing services. Its services include pediatric lead testing; heavy metal, trace element, and solvent analyses; logistical support, data management, and program management, such as courier services for medical specimen transportation, management programs for laboratory-based and on-site drug testing, coordination of specimen collection sites, and data collection/reporting; and pain management. This segment also offers forensic and clinical toxicology services; clinical testing for occupational health clinics and physician offices; and clinical testing for the pharmaceutical industry, such as general and central laboratory services, assay/test development, bio-analytical, and pharmacokinetic testing for clinical trial sponsors, clinical research organizations, and site management organizations. The Product Sales segment offers point-of-collection testing (POCT) products for drug abuse. It offers diagnostic drug screening products, such as PROFILE-II ER and PROFILE-III ER, and PROFILE-IV to hospital markets for drug detection in the hospital and emergency rooms; MEDTOXScan, an electronic reader for use with PROFILE-V MEDTOXScan device in hospital laboratories and emergency rooms; and VERDICT-II and SURE-SCREEN diagnostic drug screening products for criminal justice and drug rehabilitation markets. This segment also offers coagulation/blood clotting market controls; and distributes diagnostic tests for the detection of alcohol with the EZ-SCREEN Breath Alcohol Test. The company serves public and private companies, drug treatment counseling centers, criminal justice facilities, occupational health clinics, third party administrators, and hospitals. MEDTOX Scientific, Inc. was founded in 1983 and is based in St. Paul, Minnesota.

(login to add this stock to your watchlist or favorites)

Key Statistics

Closing Price	15.40
Volume	11995
Volume Avg	23461
52 Week High	19.21
52 Week Low	11.64
PE	30.84
PE (group average)	39
EPS Year	0.49
EPS change Q/Q	0%
EPS change Q/Q Yr ago	800%
EPS change Q/Q next Q est	-57.14%
EPS change Y/Y	-72.09%
REV change Q/Q	2.8%
REV change Q/Q Yr ago	21.23%
EPS next Q est	0.21
EPS next Y est	1.10
Divident Annual	0.00
Dividend Yield	0%